HealthQuill Clinical development
Canadian researchers have discovered a new candidate to fight drug-resistant bacteria, about three decades after the last antibiotic was developed to fight antimicrobial resistance (AMR).
Health Medical Research

Canadian researchers discover first molecule in 30 years to fight AMR

HQ Team June 9, 2025: Canadian researchers have discovered a new candidate to fight drug-resistant bacteria, about three decades after the last antibiotic.

Read More
Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered the second phase.
Drugs Pharma

Janssen’s human trials for dengue virus to advance to phase II

Janssen Pharmaceutical Companies, a wholly-owned subsidiary of Johnson & Johnson, announced its first-in-human clinical trial of a compound to treat dengue had entered.

Read More